Umbilical cord blood transplantation: current practice and future innovations

被引:63
作者
Barker, JN
Wagner, JE
机构
[1] Univ Minnesota, Sch Med, Dept Med, Blood & Marrow Transplant Program, Minneapolis, MN 55455 USA
[2] Univ Minnesota, Sch Med, Dept Pediat, Blood & Marrow Transplant Program, Minneapolis, MN 55455 USA
关键词
hematopoietic stem cells; umbilical cord blood; allogeneic transplantation; acute leukemia;
D O I
10.1016/S1040-8428(03)00092-1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
As a source of hematopoietic stem cells (HSCs), umbilical cord blood (UCB) has the advantages of speed of availability, tolerance of 1-2 antigen HLA mismatch, and a low incidence of severe GVHD. Thus, UCB represents a highly convenient HSC source that may significantly extend the HSC donor pool. UCB transplantation (UCBT) has become a standard practice in the treatment of pediatric malignancies. Now, UCBT is being investigated in adults using both conventional and non-myeloablative preparative regimens. As graft cell dose is the major factor determining hematopoietic recovery and survival in URD UCBT, methods to increase cell dose such as multiple-unit transplant and ex vivo expansion are being pursued. This review outlines the current status of UCBT with emphasis on current and future innovations. (C) 2003 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:35 / 43
页数:9
相关论文
共 47 条
[1]  
BALDUZZI A, 1995, BLOOD, V86, P3247
[2]   Bigger is better: maternal and neonatal predictors of hematopoietic potential of umbilical cord blood units [J].
Ballen, KK ;
Wilson, M ;
Wuu, J ;
Ceredona, AM ;
Hsieh, C ;
Stewart, FM ;
Popovsky, MA ;
Quesenberry, PJ .
BONE MARROW TRANSPLANTATION, 2001, 27 (01) :7-14
[3]   Searching for unrelated donor hematopoietic stem cells: Availability and speed of umbilical cord blood versus bone marrow [J].
Barker, JN ;
Krepski, TP ;
DeFor, TE ;
Davies, SM ;
Wagner, JE ;
Weisdorf, DJ .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2002, 8 (05) :257-260
[4]   Determinants of survival after human leucocyte antigen-matched unrelated donor bone marrow transplantation in adults [J].
Barker, JN ;
Davies, SM ;
DeFor, TE ;
Burns, LJ ;
McGlave, PB ;
Miller, JS ;
Weisdorf, DJ .
BRITISH JOURNAL OF HAEMATOLOGY, 2002, 118 (01) :101-107
[5]  
Barker JN, 2001, BLOOD, V98, p814A
[6]   Low incidence of Epstein-Barr virus-associated posttransplantation lymphoproliferative disorders in 272 unrelated-donor umbilical cord blood transplant recipients [J].
Barker, JN ;
Martin, PL ;
Coad, JE ;
DeFor, T ;
Trigg, ME ;
Kurtzberg, J ;
Weisdorf, DJ ;
Wagner, JE .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2001, 7 (07) :395-399
[7]   Survival after transplantation of unrelated donor umbilical cord blood is comparable to that of human leukocyte antigen-matched unrelated donor bone marrow: results of a matched-pair analysis [J].
Barker, JN ;
Davies, SM ;
DeFor, T ;
Ramsay, NKC ;
Weisdorf, DJ ;
Wagner, JE .
BLOOD, 2001, 97 (10) :2957-2961
[8]   Characterization of dendritic cell differentiation pathways from cord blood CD34+CD7+CD45RA+ hematopoietic progenitor cells [J].
Canque, B ;
Camus, S ;
Dalloul, A ;
Kahn, E ;
Yagello, M ;
Dezutter-Dambuyant, C ;
Schmitt, D ;
Schmitt, C ;
Gluckman, JC .
BLOOD, 2000, 96 (12) :3748-3756
[9]  
Cohen SBA, 1998, BONE MARROW TRANSPL, V21, pS9
[10]   The umbilical cord blood αβ T-cell repertoire:: Characteristics of a polyclonal and naive but completely formed repertoire [J].
Garderet, L ;
Dulphy, N ;
Douay, C ;
Chalumeau, N ;
Schaeffer, V ;
Zilber, MT ;
Lim, A ;
Even, J ;
Mooney, N ;
Gelin, C ;
Gluckman, E ;
Charron, D ;
Toubert, A .
BLOOD, 1998, 91 (01) :340-346